3rd Quarter - Report

KNIGHT CAPITOL CONSULTANTS for GENZYME CORPORATION

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Implementation of, and possible change/repeal to provisions related to the Patient Protection and Affordable Care Act, including implementation of biosimilars provisions. General issues related to reimbursement for pharmaceuticals, including drug pricing, orphan drugs, reimbursement for pharmaceuticals under Medicare Parts B and D, and 340B clinics.

Foreign entity interest: As identified on line 27, Genzyme is owned by Sanofi SA and public policies that benefit Genzyme will thus benefit the parent corporation as well.

LobbyistCovered position, as disclosed
PATRICIA KNIGHT Prof Staff, House Appropriations Committee

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Deficit reduction proposals that may affect the Medicare and Medicaid programs.

Foreign entity interest: As identified on line 27, Genzyme is owned by Sanofi SA and public policies that benefit Genzyme will thus benefit the parent corporation as well.

LobbyistCovered position, as disclosed
PATRICIA KNIGHT (previously listed)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

S. 606, Creating Hope Act of 2011 S. 296/H.R. 2245, Preserving Access to Life-Saving Medication Act Reauthorization of the Prescription Drug User Fee Act and possible amendments thereto (no legislation yet)

Foreign entity interest: As identified on line 27, Genzyme is owned by Sanofi SA and public policies that benefit Genzyme will thus benefit the parent corporation as well.

LobbyistCovered position, as disclosed
PATRICIA KNIGHT (previously listed)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2245 (112th), S. 606 (112th), S. 296 (112th)

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
SANOFI SA France France 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.